Canada CNF for Korean ODM K-Beauty Brands: 2026 Filing Guide

Most indie K-beauty founders map their expansion path as US first, EU second, UK third, and then quietly assume Canada will slot in without extra work. That assumption used to be mostly right. It is not right anymore. Two rule changes have redrawn the Canadian filing surface in the last eighteen months: the March 5, 2025 requirement that the Cosmetic Notification Form (CNF) carry a Canadian address on Section 4, and the April 12, 2026 rule that individual fragrance allergens must appear on the CNF and on the label whenever they exceed the concentration threshold. A Korean ODM brand that walks into either rule blind ends up with a filing rejected on validation, a Canadian importer who refuses to sign, or a fragrance-heavy essence quietly non-compliant on shelf. This guide walks a first-time Canada CNF filing end to end, written for founders who already have a Korean ODM producing their SKUs and now want to open a Canadian channel without buying six weeks of consulting hours.

What the CNF Actually Is (and Why Korean ODM Founders Get It Wrong)

The Cosmetic Notification Form is the mandatory post-market notification that Health Canada requires under the Cosmetic Regulations for every cosmetic product sold in Canada, whether domestically manufactured or imported. Under the current framework, the CNF must be filed within ten days of the first sale in Canada. That includes the first shipment to a Canadian retailer, the first pack sent to a Canadian fulfillment center, and the first direct-to-consumer order shipped across the border under a Canadian address of record. The reference source is the official Notification of Cosmetics guide on Canada.ca.

The wording matters here. Health Canada calls this a notification, not an approval. Submitting a CNF does not mean Health Canada has cleared the formula. It does not mean the ingredient roster passes the Hotlist. It does not mean the label is compliant. It only means the government has been told a product is in market so post-market surveillance can attach to it. Founders who assume that once the CNF is accepted they are done underestimate the audit posture: Health Canada or a provincial inspector can request the ingredient breakdown, the manufacturer address, the safety data, and the labelling in either language at any point, and can act on the file whenever consumer risk is identified.

The second thing Korean ODM founders often miss is that the CNF is not attached to the Korean manufacturer. It is attached to the Canadian entity responsible for the product in Canada. If your Korean ODM ships a serum into Canada under your US LLC and there is no Canadian importer or Canadian agent on record, the filing has no valid Section 4 anchor, and Health Canada will treat that as non-notification. The filing is not something the Korean lab does on your behalf. It is something you or your Canadian representative do, using data the Korean lab provides.

The 2025-2026 Rule Changes That Reshape a Korean ODM Filing

Three regulatory moves shape the current filing environment. Founders who last researched Canada before 2025 should reset their model.

First, since March 5, 2025, Section 4 of the CNF requires a Canadian address for either the manufacturer or the importer of record. A foreign address alone is no longer sufficient. If your Korean ODM is the manufacturer, and your US LLC is the notifier, and neither has a Canadian address, the form cannot be validly submitted. The practical implication for indie founders is that you either register a Canadian business entity with an operating address in Canada, or you appoint a Canadian agent or importer of record who becomes the Section 4 anchor. The March 2025 rule change is documented in industry regulatory summaries, and the underlying legal text is in the Cosmetic Regulations available on the Justice Laws Website.

Second, from April 12, 2026, individual fragrance allergens must be disclosed on the CNF and on the label whenever they exceed 0.01 percent in a rinse-off product or 0.001 percent in a leave-on product. The requirement covers a first list of 24 substances aligned with the EU List 1 allergen roster. Grouping these substances under "fragrance" or "parfum" on the CNF is no longer permitted. Health Canada's rationale is consumer safety around known contact sensitizers, and the underlying data source referenced in the consultation is the EU Scientific Committee on Consumer Safety opinion on fragrance allergens. Coverage of this change appears on CIRS Group and on the official Labelling of Cosmetics page on Canada.ca.

Third, a second list of fragrance allergens becomes disclosable on new products starting August 1, 2026, with existing products carrying a compliance date of August 1, 2028. This staggered timeline lets brands whose formulas already trip List 2 build in an inventory rotation, but it also means new SKUs launched into Canada from August 1, 2026 forward must be List 2 compliant from day one. The staggered rollout is summarized on Cosmeservice.

Layered on top of these is a parallel process: Health Canada's Cosmetic Ingredient Hotlist consultation with a comment window that closed February 17, 2026, proposing to reclassify Brucine as prohibited, restrict Polyaminopropyl Biguanide (PHMB) with a prohibition in spray products, and adjust several dye entries. The current Hotlist and the proposed amendments sit on the Cosmetic Ingredient Hotlist page and the consultation document. Founders should treat the Hotlist as a live document rather than a static list.

How to Set Up Your Canadian Importer or Agent Before You File

The Section 4 Canadian-address requirement is the gate that stops most first-time filers. There are three practical routes an indie K-beauty founder can take.

The first route is direct: incorporate a Canadian entity, lease or register a Canadian operating address, and file the CNF under that entity. This gives you full control and clean brand ownership across the border, but it commits you to Canadian corporate tax registration, GST/HST accounts, and provincial sales tax exposure. Founders selling primarily through a Canadian retailer or fulfillment operator sometimes accept this cost. Founders launching Canada as a small side channel usually do not.

The second route is to appoint a Canadian importer of record. This is a Canadian entity, often a distributor or a specialty importer, that takes title to the product on entry and becomes the notifier on the CNF. The importer does not need to be the retailer. It can be a third-party logistics operator with an importer license. What matters is that the importer accepts liability for compliance, has a Canadian operating address, and files the CNF under its own name with the product identified. This route works well for founders who have a Canadian retail partner willing to serve as importer of record, or who plan to launch on Amazon.ca with a Canadian fulfillment center that offers importer services.

The third route is a Canadian agent. This is a regulatory representative that files on behalf of a foreign notifier and takes on the Canadian-address anchor role without taking title to the product. Regulatory consultancies offer this service on retainer, and their name appears in the Section 4 field. This is the most flexible option for direct-to-consumer brands crossing the border under their own name, but it depends on the agent staying current on filings and reachable by Health Canada.

Choose the route before you start the CNF form itself. The Canadian address feeds into three subsequent sections, and switching mid-filing forces a restart. If you use an agent, get the retainer signed and the letter of appointment on file before you open the CNS portal. The consultancy world calls this the responsible person model, and it mirrors the EU CPNP Responsible Person mechanism most Korean ODM founders are already familiar with from selling into the EU.

Step-by-Step: Filing Your First CNF Through the CNS Portal

The Cosmetic Notification System (CNS) portal replaced the older submission channel and is now the required electronic path. Paper submissions are generally not accepted. Access is authenticated through GCKey or Sign-In Canada. The filing steps below follow the current portal flow.

Step one is portal registration. Create the GCKey account under the notifier entity, either the Canadian entity or the Canadian agent. Health Canada ties the account to the Section 4 address, so do not create the account under a Korean or US email that does not match the notifier of record.

Step two is company profile setup. Enter the notifier legal name, the Canadian business number if applicable, the mailing address, and the contact person. If you are filing through a Canadian agent, the agent completes this step and lists your brand entity as the party the agent represents.

Step three is product identification. Enter the product name in both English and French, the brand name, the intended function, and the physical form (liquid, cream, gel, powder, aerosol, wipes, and so on). If your Korean ODM ships one master formula under three brand names, each brand-name variant is a separate CNF. If the same formula ships in three package sizes, one CNF covers the family.

Step four is the ingredient roster. This is the highest-effort section for a Korean ODM launch. Every ingredient in the final product must be declared using its INCI name. The Korean lab's typical INCI list will use the same nomenclature standard, but the concentration ranges and any residual solvents that Health Canada expects for certain restricted ingredients need to be pulled from the lab documentation. If the formula contains any restricted ingredient from the Hotlist, the concentration must be entered and must sit inside the restricted range. If any listed fragrance allergen is present above the disclosure threshold, its individual INCI name is a separate line item.

Step five is manufacturer and formulator data. Enter the Korean ODM as the manufacturer with its Korean address, alongside the Canadian notifier as Section 4. The formulator field can be the same Korean lab if the ODM built the formula, or a separate formulator entity if your brand contracted a third-party formulator that then handed the master formula to the ODM for fill.

Step six is validation and submission. The CNS portal validates INCI spelling against the Personal Care Products Council INCI dictionary, checks the mandatory fields, and flags concentration entries that fall outside the Hotlist ranges. Fix any flags before submission. Once accepted, the portal returns a Notification Number. Save this number in your filing log. It is the reference Health Canada uses in any subsequent request, and it is the number your Canadian retailer or fulfillment operator may ask to see.

Step seven is compliance date tracking. Log the filing date, the ten-day sale window, and the Hotlist and fragrance-allergen re-check schedule. Health Canada expects the CNF to reflect the product actually on sale, so if the Korean ODM revises the formula (a new preservative system, a switch from Phenoxyethanol to a Sodium Benzoate blend, a change in extract concentration) the CNF must be updated. There is no annual renewal requirement, but there is a continuing obligation to keep the file accurate. The Notification of Cosmetics landing page on Canada.ca summarizes the ongoing obligations.

Fragrance Allergen Disclosure: What Your Korean ODM Needs to Tell You

The April 12, 2026 rule is the single biggest workflow change for indie K-beauty brands entering Canada in 2026. The rule is straightforward on its face, but its implementation exposes a common gap between Korean ODM documentation and Western regulatory needs.

The public source structure is this: any of 24 designated fragrance allergens, when present above 0.01 percent in a rinse-off product or above 0.001 percent in a leave-on product, must appear individually by INCI name on the CNF and on the retail label. Grouping them under "fragrance" or "parfum" is no longer accepted. The official labelling page confirms the mechanic.

The gap for Korean ODM founders is that many Korean labs quote a fragrance house blend to a brand as a percentage total (for example, "0.4 percent fragrance blend") without decomposing the blend into its constituent allergens. That works for the KFDA filing model, which does not require constituent disclosure for fragrance houses. It does not work for Canada in 2026. Founders have to request, from the fragrance house through the Korean ODM, an allergen certificate that lists each of the 24 allergens above the disclosure threshold present in the blend, along with its percentage of the finished product.

Practically, this means the Korean ODM needs to loop the fragrance supplier at brief stage. If the brief specifies "clean beauty" or "fragrance free" the risk is small. If the brief specifies a specific fragrance house blend (a rose blend, a citrus blend, a moss-oud accord), the founder should request the allergen certificate at the same time as the compound is quoted, not after production. Waiting until CNF filing to ask means either delaying launch by four to six weeks while the fragrance house prepares documentation, or discovering that the blend contains Citronellol, Linalool, Limonene, or Geraniol above threshold and re-doing the label at Canadian rate.

A related note: the List 2 rollout on August 1, 2026 adds additional substances aligned with EU regulatory expansion. For new SKUs launching from August 1, 2026 onward, request the fragrance house certificate covering both List 1 and List 2, not just List 1. Existing SKUs already in the Canadian market have until August 1, 2028 to add List 2 disclosure. Do not treat that grace window as an excuse to file with List 1 only for a new SKU launching now.

Bilingual Labelling and INCI Disclosure: Getting the Label Right

Canada's bilingual labelling requirement is a compliance step that catches Korean ODM founders off guard when they compare it to US or EU workflow. Under Section 18 of the Cosmetic Regulations, all mandatory label information must appear in both English and French. Both languages must be equally legible and equally prominent. The one exception is the ingredient list itself, which is presented in INCI, and INCI names are considered universal and do not require French translation.

What must be bilingual, then, is everything else: the product identity statement, the net quantity declaration, the manufacturer or importer name and address, any function claims that appear on the pack, any usage or precaution statements, and any promotional or descriptive text. The Korean ODM's stock label template usually has an English side and a Korean side, and neither maps to the Canadian requirement. Founders have to either commission a bilingual label design specifically for the Canadian market or, if selling into the US and Canada with the same pack, design the label to accommodate both languages from the outset.

The INCI carve-out matters for a reason worth stating clearly. The ingredient list itself is a single block of INCI names, in descending order of concentration for ingredients above one percent and in any order for ingredients at or below one percent, and that single block satisfies both languages. Founders can save real design real estate by getting this rule right. Where founders lose real estate is in the promotional copy: any "hydrates for 24 hours" or "brightens dull skin" claim that appears on the pack has to appear in French with equivalent prominence. Design early, translate early, and validate the French rendering with a Quebec French copywriter rather than European French, since the Office québécois de la langue française applies its own norms to Quebec sales specifically.

Common Mistakes Indie Founders Make on Canadian CNF Filings

Four mistakes surface again and again in first-time Canadian filings from indie K-beauty brands with Korean ODM production.

The first is filing after first sale rather than within the ten-day window. Founders read "notification" as "post-market" and interpret it as flexible. The regulation is specific: within ten days of first sale in Canada. A test shipment to a Canadian retail buyer counts as first sale. A pre-launch Amazon Vine campaign that ships to Canadian addresses counts as first sale. The best posture is to have the CNF filed and the Notification Number in hand before the first Canadian pack ships, not after.

The second is under-populating the ingredient list. The Korean ODM's fill sheet often lists functional ingredients and skips certain processing aids or residual solvents that are still present in the finished product below trace levels. If the residual is above the CNF disclosure threshold, it belongs on the notification even if the ODM did not include it in the marketing INCI list. Ask the Korean lab for the full compositional breakdown, not the marketing INCI list, and reconcile the two before filing.

The third is treating the Section 4 Canadian address as pro forma. Founders sometimes list a friend's Toronto address or a coworking space as the notifier address, thinking Section 4 is administrative. It is not. It is the address of the party legally responsible for the product in Canada, and Health Canada may contact that address for post-market safety information, incident reports, or recall coordination. If the address is not staffed by someone who can respond within the timeframe Health Canada expects, the notification is functionally broken.

The fourth is skipping the Hotlist check on the Korean master formula. Korean labs formulate to KFDA rules and to their own internal quality bar, both of which are strong, but they do not read the Canadian Hotlist as a matter of course. Ingredients that are freely used in Korea can appear on the Hotlist as restricted or prohibited in Canada. The Hotlist page on Canada.ca is the definitive reference, and it changes. A responsible pre-filing workflow runs the full ingredient roster against the current Hotlist within thirty days of filing, not against a Hotlist snapshot from six months earlier.

A Note From Liz

I'm Liz, I run altameet from Manhattan, NYC. Canada tends to be the market that indie K-beauty founders defer, because the regulatory calendar shifted twice inside eighteen months and the new rules are not the ones most existing guides cover. If you are trying to line up a Canadian launch alongside your US expansion and want a quick gut-check on whether your Korean ODM's documentation is CNF-ready, or on whether your fragrance blend risks the April 2026 threshold, I will give you fifteen minutes free. Reach me at liz@altameet.com or the team at partnerships@altameet.com. We work across NYC and Seoul, so we can loop the Korean lab on the same call if that helps.

Working With ALTA MEET on Canada CNF Prep

For indie K-beauty brands moving into Canada from a Korean ODM base, the most useful support is upstream of filing: the pre-filing Hotlist scan against the current master formula, the fragrance-allergen decomposition request routed through the Korean ODM to the fragrance house, the Canadian agent or importer-of-record introduction, and the bilingual label review against the Cosmetic Regulations Section 18 requirements. Downstream, the CNS portal filing itself is a specific-hour engagement and not the place brands need the most help.

If you have an existing US market presence and are preparing your first Canada SKU launch, our engagement usually looks like a two-hour pre-filing scan followed by a Canadian agent referral if you do not already have Canadian presence. If you are launching Canada as your first Western market before US, the sequence looks different: we usually recommend anchoring the Canadian entity structure first so the Section 4 address is stable, and then filing the US MOCRA registration afterward against a business already legally present in North America. Either way, the Korean ODM is looped in on the compositional data request early, so the fragrance certificate is in hand before formula lock, not after.

The related pieces on importing Korean cosmetics to the USA, UK SCPN filing, and EU CPNP registration cover the parallel filings founders typically bundle with Canada.

Key Takeaways

1. The CNF must be filed within ten days of first sale in Canada, including test shipments and pre-launch fulfillment.
2. Since March 5, 2025, Section 4 of the CNF requires a Canadian address. Foreign-only notifiers are not accepted. Appoint a Canadian agent or importer of record before filing.
3. From April 12, 2026, individual fragrance allergens above 0.01 percent (rinse-off) or 0.001 percent (leave-on) must appear on both the CNF and the label. Request the allergen certificate from your Korean ODM at brief stage, not at filing.
4. A second fragrance allergen list phases in for new products from August 1, 2026, with existing products compliant by August 1, 2028.
5. The Hotlist is a live document. Run the Korean master formula against the current Hotlist within thirty days of filing.
6. Bilingual labelling covers all mandatory information except the INCI ingredient list. Design the label bilingual from the outset if it also serves the US market.
7. Filing is electronic through the CNS portal with GCKey or Sign-In Canada authentication. Paper is not accepted.

Frequently Asked Questions

Do I need a Canadian bank account or Canadian corporation to file a CNF?
No. You need a Canadian address on Section 4. That can be a Canadian corporation, a Canadian importer of record, or a Canadian regulatory agent. A Canadian bank account is not a CNF requirement, though most Canadian retailers will require one before onboarding you as a supplier.

Can my Korean ODM file the CNF on my behalf?
No. The CNF is a notification by the party legally responsible for the product in Canada, which is the Canadian notifier of record, not the manufacturer overseas. The Korean ODM provides the compositional data, the manufacturer address, and any supporting safety documentation. The notifier or its agent submits the form.

What happens if I sell first and file the CNF late?
Filing after the ten-day window puts you out of compliance with the Cosmetic Regulations. Health Canada can request voluntary product removal or issue enforcement, and Canadian retailers may pull the SKU. The practical remedy is to file immediately and note the late-filing status. Do not backdate the filing.

Does the fragrance allergen rule apply if my product is fragrance-free?
If the product contains no fragrance blend and no listed allergen is present as a botanical extract constituent above the disclosure threshold, no additional line items are required. Botanical extracts, however, can carry Linalool, Limonene, and other listed allergens naturally, so a formula labelled fragrance-free is not automatically outside the rule. Ask the Korean ODM for the compositional breakdown of any botanical extract in the formula.

Do I need to re-file the CNF every year?
There is no annual renewal. The CNF is a one-time notification per SKU. However, any change to the formula, the manufacturer, the notifier, or the product identity requires an updated CNF, and Health Canada expects the notification on file to reflect the product actually sold.

Does the CNS portal accept the Korean ODM's INCI list directly, or does it need conversion?
The CNS portal validates INCI names against the Personal Care Products Council dictionary. Korean ODMs typically supply INCI names in a compatible format, but any Korean-domestic ingredient identifiers or Korean cosmetic ingredient database identifiers need to be mapped to the INCI equivalent before entry. Ask the Korean lab for the INCI list specifically, not the Korean CID list.

How does Canada CNF compare to UK SCPN and EU CPNP for a Korean ODM brand?
All three are notifications, not approvals. The EU CPNP model uses a Responsible Person, the UK SCPN model uses a Responsible Person for Great Britain, and the Canadian CNF model uses a Canadian notifier with a Canadian address. The compositional data requirement is similar across all three, so a founder that has already assembled EU CPNP or UK SCPN documentation is most of the way to the Canadian data package. The three notable Canada-specific pieces are the bilingual labelling, the Hotlist, and the fragrance allergen rule with its 2026 and 2028 dates.

By the ALTA MEET editorial team | K-beauty ODM consulting

Reviewed for accuracy by ALTA MEET's regulatory consulting team.